Get the Stockscreener App
1.17
2.63%
0.03
After Hours:
1.13
-0.04
-3.42%
Alx Oncology Holdings Inc stock is traded at $1.17, with a volume of 521.48K.
It is up +2.63% in the last 24 hours and up +101.72% over the past month.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
See More
Previous Close:
$1.14
Open:
$1.14
24h Volume:
521.48K
Relative Volume:
0.59
Market Cap:
$62.65M
Revenue:
-
Net Income/Loss:
$-151.16M
P/E Ratio:
-0.3939
EPS:
-2.97
Net Cash Flow:
$-130.08M
1W Performance:
+0.00%
1M Performance:
+101.72%
6M Performance:
+9.35%
1Y Performance:
-49.13%
1-Day Range:
$1.10
$1.1785
1-Week Range:
$1.05
$1.25
52-Week Range:
$0.404
$2.3655
Alx Oncology Holdings Inc Stock (ALXO) Company Profile
Name
Alx Oncology Holdings Inc
Sector
Industry
Phone
650-466-7125
Address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Compare ALXO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALXO
Alx Oncology Holdings Inc
|
1.17 | 61.05M | 0 | -151.16M | -130.08M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-19-24 | Downgrade | Jefferies | Buy → Hold |
| Mar-08-24 | Downgrade | Stifel | Buy → Hold |
| Dec-08-23 | Upgrade | Jefferies | Hold → Buy |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-30-21 | Initiated | Stifel | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Apr-06-21 | Initiated | UBS | Buy |
| Feb-10-21 | Initiated | H.C. Wainwright | Buy |
| Aug-11-20 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-11-20 | Initiated | Credit Suisse | Outperform |
| Aug-11-20 | Initiated | Jefferies | Buy |
| Aug-11-20 | Initiated | Piper Sandler | Overweight |
View All
Alx Oncology Holdings Inc Stock (ALXO) Latest News
Using AI based signals to follow ALX Oncology Holdings Inc.Quarterly Portfolio Review & Reliable Volume Spike Trade Alerts - Newser
Is ALX Oncology Holdings Inc. stock ready for a breakoutPortfolio Gains Report & Safe Swing Trade Setups - Newser
When is the best time to exit ALX Oncology Holdings Inc.Trade Ideas & Intraday High Probability Setup Alerts - Newser
Is ALX Oncology Holdings Inc. reversing from oversold territoryEarnings Summary Report & Consistent Income Trade Recommendations - Newser
Reversal indicators forming on ALX Oncology Holdings Inc. stockGlobal Markets & High Accuracy Swing Entry Alerts - Newser
Chart based exit strategy for ALX Oncology Holdings Inc.Bond Market & AI Powered Market Trend Analysis - Newser
Exit strategy if you’re trapped in ALX Oncology Holdings Inc.2025 Trading Volume Trends & Community Verified Swing Trade Signals - Newser
Using AI based signals to follow ALX Oncology Holdings Inc2025 Year in Review & Technical Confirmation Trade Alerts - Newser
Can momentum traders help lift ALX Oncology Holdings Inc.2025 Big Picture & Weekly High Return Opportunities - Newser
ALX Oncology Holdings Inc. stock volume spike explainedJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - Newser
ALX Oncology Holdings Inc. stock outlook for YEARJuly 2025 Final Week & Daily Profit Focused Stock Screening - Newser
ALX Oncology Holdings Inc. recovery potential after sell offWeekly Trend Recap & Community Trade Idea Sharing - Newser
Is this a good reentry point in ALX Oncology Holdings Inc.Market Performance Report & Stock Portfolio Risk Control - Newser
Applying big data sentiment scoring on ALX Oncology Holdings Inc.Market Performance Report & High Accuracy Investment Signals - Newser
Published on: 2025-08-31 01:36:23 - Newser
ALX Oncology Holdings Inc. stock daily chart insightsJuly 2025 Update & Free Real-Time Market Sentiment Alerts - Newser
Does ALX Oncology Holdings Inc. show high probability of reboundJuly 2025 Intraday Action & Community Consensus Stock Picks - Newser
What the charts say about ALX Oncology Holdings Inc. todayLayoff News & Risk Controlled Stock Pick Alerts - Newser
Will ALX Oncology Holdings Inc. see short term momentumJuly 2025 Review & Daily Technical Forecast Reports - Newser
ALX Oncology Holdings Inc. stock trendline breakdownWeekly Trend Report & Smart Money Movement Alerts - Newser
Risk vs reward if holding onto ALX Oncology Holdings Inc.2025 Short Interest & Reliable Price Action Trade Plans - Newser
Using R and stats models for ALX Oncology Holdings Inc. forecastingJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - Newser
ALX Oncology Holdings Inc. stock trend forecastQuarterly Trade Report & Step-by-Step Swing Trade Plans - Newser
Top chart patterns to watch in ALX Oncology Holdings Inc.Weekly Stock Recap & Detailed Earnings Play Alerts - Newser
Published on: 2025-08-29 15:48:11 - Newser
ALX Oncology shares fall 1.75% intraday as leadership participates in upcoming investor conferences. - AInvest
ALX Oncology to Participate in Upcoming Investor Conferences in September - The Manila Times
Clinical-Stage Biotech ALX Oncology Announces Dual Conference Presentations in September 2025 - Stock Titan
Alx Oncology Holdings Inc Stock (ALXO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):